We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidance Seeks to Clarify Formatting Issues With Individual Case Safety Reports
Guidance Seeks to Clarify Formatting Issues With Individual Case Safety Reports
July 24, 2013
The FDA wants drugmakers to fully understand that non-expedited individual case safety reports (ICSRs), filed alongside periodic adverse drug experience reports, shouldn’t be submitted in portable document format (PDF) but in extensive markup language (XML).